CAR-T cell infusion

BIOLOGICAL3 trials

Sponsors

The Affiliated Hospital of Xuzhou Medical University, PersonGen BioTherapeutics (Suzhou) Co., Ltd., Dr. Zaineb Akram

Conditions

Acute T-lymphoblastic LeukemiaAcute T-lymphoblastic LymphomaHematolymphoid MalignanciesRelapsed Acute Lymphoblastic Leukemia (ALL)

Early Phase 1

Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies

RecruitingNCT07338604

PersonGen BioTherapeutics (Suzhou) Co., Ltd.Hematolymphoid Malignancies

Start: 2025-12-12End: 2027-12-31Target: 15Updated: 2026-01-14

CAR-T Cell Therapy for ALL

RecruitingNCT07695012

Dr. Zaineb AkramRelapsed Acute Lymphoblastic Leukemia (ALL)

Start: 2026-06-01End: 2027-12-31Target: 10Updated: 2026-07-10

Phase 2

Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma

The Affiliated Hospital of Xuzhou Medical UniversityAcute T-lymphoblastic Leukemia, Acute T-lymphoblastic Lymphoma

Start: 2023-02-01End: 2026-01-01Target: 20Updated: 2023-02-27